Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1266P (RNA, U6 small nuclear 1266, pseudogene) is a non-coding RNA pseudogene derived from the gene encoding U6 small nuclear RNA, which is a highly conserved snRNA essential for mRNA splicing in the spliceosome[2][3][5]. As a pseudogene, RNU6-1266P does not produce functional U6 snRNA and is not directly involved in the catalytic splicing reaction[2][5]. Pseudogenes like RNU6-1266P are considered non-functional remnants of gene evolution, though some pseudogenes can act through RNA-based regulatory mechanisms (such as generating non-coding RNAs that interact with microRNAs or mRNAs), but no specific evidence exists for RNU6-1266P performing such a role[4][6]. It is not considered a therapeutic target, nor does it have a characterized role as a biomarker or disease gene. The presence of many U6 snRNA pseudogenes in the human genome underscores the evolutionary importance of the U6 snRNA, but these pseudogenes themselves are typically biologically inert[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1266, pseudogene (RNU6-1266P).